Evidence map›Paper›PMID 40978342›Full record

ArticleACS omega2025

Analytical Development for Detecting Femtomole-Level Organophosphorus Compounds in Biogeochemical Samples by Ion Chromatography/High-Resolution Mass Spectrometry.

Yuta Hirakawa, Toshiki Koga, Takahiro Suzuki, Naohiko Ohkouchi, Yoshinori Takano

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuta HirakawaBiogeochemistry Research Center (BGC), Japan Agency for Marine-Earth Science and Technology (JAMSTEC), 2-15 Natsushima, Yokosuka 237-0061, Japan.ORCID https://orcid.org/0009-0002-5323-4276
Toshiki KogaBiogeochemistry Research Center (BGC), Japan Agency for Marine-Earth Science and Technology (JAMSTEC), 2-15 Natsushima, Yokosuka 237-0061, Japan.ORCID https://orcid.org/0000-0001-5728-0590
Takahiro SuzukiThermo Fisher Scientific Inc., 3-9 Moriyacho, Kanagawa-ku, Yokohama, Kanagawa 221-0022, Japan.
Naohiko OhkouchiBiogeochemistry Research Center (BGC), Japan Agency for Marine-Earth Science and Technology (JAMSTEC), 2-15 Natsushima, Yokosuka 237-0061, Japan.
Yoshinori TakanoBiogeochemistry Research Center (BGC), Japan Agency for Marine-Earth Science and Technology (JAMSTEC), 2-15 Natsushima, Yokosuka 237-0061, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phosphorus (P) is a crucial element for life, and its organic forms play a central role in modern biology. Therefore, the analysis of their presence in environmental samples is important for evaluating the biogeochemistry of P and the P cycle on the Earth. Herein, we developed a high-sensitivity, high-resolution analytical technique for detecting organophosphorus compounds using ion chromatography (IC) with Orbitrap-mass spectrometry (Orbitrap-MS). The IC method clearly separated organophosphorus compounds, including alkyl phosphonates and alkyl phosphates, from other organic molecules and inorganic ions. The online combination of IC and Orbitrap-MS enabled the quantification of organophosphorus compounds with concentrations as low as ∼10 fmol and their molecular identification in the presence of various interfering organic substances. The feasibility of the developed and optimized IC-Orbitrap-MS method was confirmed by analyzing deep-sea sediments obtained from 343 m below the seafloor. This developed analytical technique can also be applied to biogeochemical and astrochemical molecular surveys of organophosphorus compounds in natural environments.

Identifiers

PMID40978342
PMCPMC12444523

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.